Breast Cancer Screening Program: Findings from a Population-Based Study in South Nigeria
Main Article Content
Abstract
BACKGROUND: Breast cancer is the most common cancer among women in both developed and developing countries, affecting about 2 million women and causing 6.6% of all cancer deaths each year. Although developed countries have higher rates of breast cancer, the availability of structured screening programmes enables early detection and thus prevention of morbidity and mortality.
AIMS: This article presents the findings of a 10‑year population‑based breast cancer screening programme by a member state of the Medical Women’s Association of Nigeria (MWAN).
METHODS: A retrospective exploration of the database of MWAN Akwa Ibom state was carried out for 10 years of 2008–2017.
RESULTS: A total of 2203 women were screened for breast cancer between 2008 and 2017. Majority were 31–40 years (36.9%) and married (56.8%). Only 27% did monthly self‑breast examinations. On clinical breast examination (CBE), breast lump was found in 166 (7.5%) of the respondents, with the most common location being the left outer upper quadrant. An enlarged lymph node was seen in only 1% of the population. Clients aged 20 years or less (24.5%) and those living with a partner (16.1%) formed a significantly higher proportion of those with a breast lump. Respondents who had never breast fed had a significantly higher percentage of breast lumps compared to those who had (10.1%).
CONCLUSION: This study found that breast lumps were more common in the younger population and those living with partners. Non‑breastfeeding was seen to be associated with an increased risk of developing breast lumps. Routine monthly breast self‑examination, regular clinical breast examination and follow‑up of individuals with breast lesions are recommended to facilitate early detection of breast cancer in our resource‑poor setting. We also recommend reduced age of screening for breast lumps and CBE for younger women.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394‑424.
Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: The case of Sub‑Saharan Africa (with emphasis on Nigeria) and implications for regional development: A review. World J Surg Oncol 2018;16:63.
Black E, Richmond R. Improving early detection of breast cancer in Sub‑Saharan Africa: Why mammography may not be the way forward. Global Health 2019;15:3.
WHO | Breast Cancer. WHO. World Health Organization. Available from: http://www.who.int/cancer/prevention/diagnosis‑screening/breast‑cancer/en/. [Last accessed on 2020 Sep 29].
WHO | Breast cancer: Prevention and control [Internet]. WHO. World Health Organization. Available from: http://www.who.int/cancer/detection/breastcancer/en/. [Last accessed on 2020 Oct 12].
Johnson OE. Awareness and practice of breast self examination among women in different African countries: A 10‑year review of literature. Niger Med J 2019;60:219‑25.
Oberaigner W, Buchberger W, Frede T, Knapp R, Marth C, Siebert U. Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening. BMC Public Health 2010;10:86.
Khil L, Heidrich J, Wellmann I, Kääb‑Sanyal V, Weigel S, Heindel W, et al. Incidence of advanced‑stage breast cancer in regular participants of a mammography screening program: A prospective register‑based study. BMC Cancer 2020;20:174.
Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A,et al. Efficacy of breast cancer screening by age. New results from the Swedish two‑county trial. Cancer 1995;75:2507‑17.
Yang L, Wang S, Zhang L, Sheng C, Song F, Wang P, et al.Performance of ultrasonography screening for breast cancer: a systematic review and meta‑analysis. BMC Cancer 2020;20:499.
World Health Organization. WHO position paper on mammography screening. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/iris/bitstream/10665/137339/1/9789241507936_eng.pdf?ua=1. [Last accessed on 2020 Sep 29].
Zelle SG, Nyarko KM, Bosu WK, Aikins M, Niëns LM, Lauer JA,et al. Costs, effects and cost‑effectiveness of breast cancer control in Ghana. Trop Med Int Health 2012;17:1031‑43.
Corbex M, Burton R, Sancho‑Garnier H. Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast 2012;21:428‑34.
IARC, WHO. Testing and reporting the results of visual inspection with 5% acetic acid (VIA). A practical manual on visual screening for cervical neoplasia. Available from: https://screening.iarc.fr/viavilichap2.php?lang=1. [Last accessed on 2021 Apr 29].
Msami K, Mbwana M, Mwaiselage J, Nyagabona S, Makani J, Dharsee N, et al. Developing research education groups in African cancer centers: The experience in Tanzania. J Cancer Educ 2021;36:101‑8.
Odedina SO, Ajayi IO, Adeniji‑Sofoluwe A, Morhason‑Bello IO, Huo D, Olopade OI, et al. A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, outhwestern Nigeria. BMC Womens Health 2018;18:152.
Florence AO, Felicia AE, Dorcas AA, Ade‑Aworetan FA. An assessment of the knowledge and practice of self breast examination (BSE) amongst University Students. Health (N Y) 2016;8:409‑15.
Perry MC. Breast lump. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279/. [Last accessed on 2020 Oct 12].
Yusufu LM, Odigie VI, Mohammed A. Breast masses in Zaria, Nigeria. Ann Afr Med 2003;2:13‑6.
Tulinius H, Sigvaldason H, Olafsdóttir G. Left and right sided breast cancer. Pathol Res Pract 1990;186:92‑4.
Fatima N, Zaman MU, Maqbool A, Khan SH, Riaz N. Lower incidence but more aggressive behavior of right sided breast cancer in Pakistani women: does right deserve more respect? Asian Pac J Cancer Prev 2013;14:43‑5.
Weiss HA, Devesa SS, Brinton LA. Laterality of breast cancer in the United States. Cancer Causes Control 1996;7:539‑43.
Ekbom A, Adami HO, Trichopoulos D, Lambe M, Hsieh CC, Pontén J. Epidemiologic correlates of breast cancer laterality (Sweden). Cancer Causes Control 1994;5:510‑6.
Perkins CI, Hotes J, Kohler BA, Howe HL. Association between breast cancer laterality and tumor location, United States, 1994‑1998. Cancer Causes Control 2004;15:637‑45.
Roychoudhuri R, Putcha V, Møller H. Cancer and laterality: A study of the five major paired organs (UK). Cancer Causes Control 2006;17:655‑62.26. CDC Breast Cancer. What Are the Symptoms of Breast Cancer? Centers for Disease Control and Prevention. 2020. Available from: https://www.cdc.gov/cancer/breast/basic_info/symptoms.htm. [Last accessed on 2020 Oct 13].
Alawi A, Hasan M, Harraz MM, Kamr WH, Alsolami S, Mowalwei H, et al. Breast lesions in women under 25 years: Radiologic‑pathologic correlation. Egypt J Radiol Nucl Med 2020;51:96.
Brinton LA, Hoover R, Fraumeni JF Jr. Reproductive factors in the aetiology of breast cancer. Br J Cancer 1983;47:757‑62.
Al‑Ajmi K, Lophatananon A, Ollier W, Muir KR. Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors. PLoS One 2018;13:e0201097.
Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta‑analysis of epidemiological studies. Cancer Treat Rev 2016;49:65‑76.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187‑95.
Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat 2017;165:193‑200.
Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr.,et al. Alcohol, tobacco and breast cancer‑collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002;87:1234‑45.
Bardaweel SK, Akour AA, Al‑Muhaissen S, AlSalamat HA, Ammar K. Oral contraceptive and breast cancer: do benefits outweigh the risks? A case‑control study from Jordan. BMC Womens Health 2019;19:72.
Michels KA, Pfeiffer RM, Brinton LA, Trabert B. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA Oncol 2018;4:516‑21.